Heterogeneity maintenance in glioblastoma: a social network.
暂无分享,去创建一个
W. Cavenee | F. Furnari | M. Inda | R. Bonavia | Frank B Furnari | Webster K Cavenee | Maria-del-Mar Inda | Rudy Bonavia
[1] Luke A. Gilbert,et al. DNA Damage-Mediated Induction of a Chemoresistant Niche , 2010, Cell.
[2] P. Kleihues,et al. Predominant Expression of Mutant EGFR (EGFRvIII) is Rare in Primary Glioblastomas , 2004, Brain pathology.
[3] W. Cavenee,et al. Immunohistochemical analysis of the mutant epidermal growth factor, ΔEGFR, in glioblastoma , 2006, Brain Tumor Pathology.
[4] M. Greaves. Cancer stem cells: back to Darwin? , 2010, Seminars in cancer biology.
[5] Mark W. Dewhirst,et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response , 2006, Nature.
[6] A. Maleci,et al. Prostaglandin E2 as an immunomodulating factor released in vitro by human glioma cells , 2004, Acta Neuropathologica.
[7] Erwin G. Van Meir,et al. Cells with TP53 mutations in low grade astrocytic tumors evolve clonally to malignancy and are an unfavorable prognostic factor , 1999, Oncogene.
[8] Michael R. Green,et al. A Cell-Surface Receptor for Lipocalin 24p3 Selectively Mediates Apoptosis and Iron Uptake , 2005, Cell.
[9] D. Gutmann,et al. Astrocyte-specific expression of activated p21-ras results in malignant astrocytoma formation in a transgenic mouse model of human gliomas. , 2001, Cancer research.
[10] P. Black,et al. αvβ3 and αvβ5 Integrin Expression in Glioma Periphery , 2001 .
[11] 古賀 一成. Expression of angiopoietin-2 in human glioma cells and its role for angiogenesis , 2002 .
[12] W. Shapiro,et al. Heterogeneous chemosensitivities of subpopulations of human glioma cells in culture. , 1982, Cancer research.
[13] C. Heldin,et al. Platelet-derived growth factor and its receptors in human glioma tissue: expression of messenger RNA and protein suggests the presence of autocrine and paracrine loops. , 1992, Cancer research.
[14] I. Bayazitov,et al. A perivascular niche for brain tumor stem cells. , 2007, Cancer cell.
[15] P. Black,et al. Alpha(v)beta3 and alpha(v)beta5 integrin expression in glioma periphery. , 2001, Neurosurgery.
[16] Jian Wang,et al. CD133 negative glioma cells form tumors in nude rats and give rise to CD133 positive cells , 2008, International journal of cancer.
[17] K. Sasaki,et al. Intratumoral cytogenetic heterogeneity detected by comparative genomic hybridization and laser scanning cytometry in human gliomas. , 1998, Cancer research.
[18] Mary R. Myerscough,et al. Clonal diversity in carcinomas: its implications for tumour progression and the contribution made to it by epithelial-mesenchymal transitions , 2007, Clinical & Experimental Metastasis.
[19] I. Fidler,et al. Metastasis results from preexisting variant cells within a malignant tumor. , 1977, Science.
[20] Serban Nacu,et al. A hierarchy of self-renewing tumor-initiating cell types in glioblastoma. , 2010, Cancer cell.
[21] Yoshitaka Narita,et al. Tumor heterogeneity is an active process maintained by a mutant EGFR-induced cytokine circuit in glioblastoma. , 2010, Genes & development.
[22] R. Henkelman,et al. Identification of human brain tumour initiating cells , 2004, Nature.
[23] N. Altorki,et al. TGF-β IL-6 axis mediates selective and adaptive mechanisms of resistance to molecular targeted therapy in lung cancer , 2010, Proceedings of the National Academy of Sciences.
[24] P. Nowell. The clonal evolution of tumor cell populations. , 1976, Science.
[25] David García-Dorado,et al. TGF-beta increases glioma-initiating cell self-renewal through the induction of LIF in human glioblastoma. , 2009, Cancer cell.
[26] A. Aguzzi,et al. IL-6 is required for glioma development in a mouse model , 2004, Oncogene.
[27] M. Brada. Pathology and Genetics of Tumours of the Nervous System , 2001, British Journal of Cancer.
[28] H. Colman,et al. Glioblastoma Cancer-Initiating Cells Inhibit T-Cell Proliferation and Effector Responses by the Signal Transducers and Activators of Transcription 3 Pathway , 2010, Molecular Cancer Therapeutics.
[29] K. Black,et al. Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma , 2006, Molecular Cancer.
[30] Webster K. Cavenee,et al. Pathology and genetics of tumours of the nervous system. , 2000 .
[31] W. Shapiro,et al. Isolation, karyotype, and clonal growth of heterogeneous subpopulations of human malignant gliomas. , 1981, Cancer research.
[32] T. Crowe,et al. Epithelial cells up-regulate matrix metalloproteinases in cells within the same mammary carcinoma that have undergone an epithelial-mesenchymal transition. , 1998, Cancer research.
[33] J. Huse,et al. Genetically Engineered Mouse Models of Brain Cancer and the Promise of Preclinical Testing , 2008, Brain pathology.
[34] D. Tarin,et al. Dormant cancer cells retrieved from metastasis-free organs regain tumorigenic and metastatic potency. , 2006, The American journal of pathology.
[35] K. Nabeshima,et al. Expression of c‐Met correlates with grade of malignancy in human astrocytic tumours: an immunohistochemical study , 1997, Histopathology.
[36] J. Herman,et al. Correlation of O6-methylguanine methyltransferase (MGMT) promoter methylation with clinical outcomes in glioblastoma and clinical strategies to modulate MGMT activity. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[37] M. Berens,et al. Autocrine factors that sustain glioma invasion and paracrine biology in the brain microenvironment. , 2007, Journal of the National Cancer Institute.
[38] D. Bigner,et al. Demonstration of complex antigenic heterogeneity in a human glioma cell line and eight derived clones by specific monoclonal antibodies. , 1983, Cancer research.
[39] L. Chin,et al. Malignant astrocytic glioma: genetics, biology, and paths to treatment. , 2007, Genes & development.
[40] H. Wiley,et al. The Enhanced Tumorigenic Activity of a Mutant Epidermal Growth Factor Receptor Common in Human Cancers Is Mediated by Threshold Levels of Constitutive Tyrosine Phosphorylation and Unattenuated Signaling* , 1997, The Journal of Biological Chemistry.
[41] J. Moringlane,et al. Evidence of focal genetic microheterogeneity in glioblastoma multiforme by area-specific CGH on microdissected tumor cells. , 1999, Journal of neuropathology and experimental neurology.